Severe acute respiratory syndrome coronavirus 2, primarily a respiratory tract virus, also affects the enteric organs. The most affected sector of the community are the retirement and nursing home elderly residents. Along their life the senescent gastrointestinal functions are deteriorating and failing to fully execute their digestive, absorptive, mucosal barriers, and immune protective duties. Adding the decreased motility, increased intestinal permeability, dysbiosis, morbid chronic disease background, the consumed polypharmacy enteric adverse effects to the presence of the SARS-CoV-2 host receptor along the intestinal tracts put the basis for the current hypothesis. It is hypothesized that the disadvantages and failures of the aging enteric tract contribute to the elderly morbidity and mortality during the current new coronavirus pandemic. In a more optimistic look, several nutraceuticals can prevent or restore the dysfunctional intestinal barrier functions, mainly in the elderly and potentially in those who are SARS-CoV-2 infected.
【저자키워드】 COVID-19, elderly, nutraceuticals, morbidity, gastrointestinal tract dysfunction, 【초록키워드】 SARS-CoV-2, coronavirus, pandemic, virus, immune, chronic disease, Community, morbidity and mortality, respiratory tract, nutraceutical, function, Protective, New coronavirus, mucosal, Hypothesis, intestinal permeability, disadvantage, adverse effect, acute respiratory syndrome, host receptor, functions, intestinal tract, organs, Affect, Prevent, intestinal, affected, contribute, digestive, senescent, Adding, the SARS-CoV-2, 【제목키워드】 aging, vulnerability,